SNOA Sonoma Pharmaceuticals, Inc.

Nasdaq sonomapharma.com


$ 3.71 $ -0.11 (-2.93 %)    

Thursday, 06-Nov-2025 15:59:50 EST
QQQ $ 612.31 $ -11.61 (-1.86 %)
DIA $ 469.50 $ -3.83 (-0.81 %)
SPY $ 671.30 $ -7.27 (-1.07 %)
TLT $ 89.70 $ 0.80 (0.9 %)
GLD $ 365.69 $ -0.44 (-0.12 %)
$ 3.65
$ 3.71
$ 3.20 x 800
$ 3.88 x 1
$ 3.55 - $ 3.84
$ 1.75 - $ 6.92
24,596
na
6.4M
$ 1.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 06-17-2025 03-31-2025 10-K
4 02-05-2025 12-31-2024 10-Q
5 11-07-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 06-17-2024 03-31-2024 10-K
8 02-08-2024 12-31-2023 10-Q
9 11-13-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 06-21-2023 03-31-2023 10-K
12 02-14-2023 12-31-2022 10-Q
13 11-14-2022 09-30-2022 10-Q
14 08-11-2022 06-30-2022 10-Q
15 07-13-2022 03-31-2022 10-K
16 02-11-2022 12-31-2021 10-Q
17 11-15-2021 09-30-2021 10-Q
18 08-16-2021 06-30-2021 10-Q
19 07-14-2021 03-31-2021 10-K
20 02-16-2021 12-31-2020 10-Q
21 11-20-2020 09-30-2020 10-Q
22 08-14-2020 06-30-2020 10-Q
23 07-10-2020 03-31-2020 10-K
24 02-14-2020 12-31-2019 10-Q
25 11-14-2019 09-30-2019 10-Q
26 08-13-2019 06-30-2019 10-Q
27 07-01-2019 03-31-2019 10-K
28 02-14-2019 12-31-2018 10-Q
29 11-08-2018 09-30-2018 10-Q
30 08-08-2018 06-30-2018 10-Q
31 06-26-2018 03-31-2018 10-K
32 02-14-2018 12-31-2017 10-Q
33 11-14-2017 09-30-2017 10-Q
34 08-08-2017 06-30-2017 10-Q
35 06-28-2017 03-31-2017 10-K
36 02-17-2017 12-31-2016 10-Q
37 11-15-2016 09-30-2016 10-Q
38 08-09-2016 06-30-2016 10-Q
39 06-21-2016 03-31-2016 10-K
40 02-16-2016 12-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sonoma-pharmaceuticals-q2-eps-032-misses-031-estimate-sales-5604m-beat-4261m-estimate

Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate...

 sonoma-pharmaceuticals-terminates-evp-and-coo-bruce-thornton-for-cause-effective-october-18-2025

On October 18, 2025, Bruce Thornton was terminated as an employee and Executive Vice President and Chief Operating Officer of t...

 sonoma-pharmaceuticals--enters-at-market-issuance-sales-agreement-with-ladenburg-to-pay-3-commission-to-ladenburg-on-share-sales

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001367083/000168316825007265/sonoma_8k.htm

 5-healthcare-stocks-on-fire-this-week

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech &...

Core News & Articles

WULF: 24% | TeraWulf shares are trading higher after the company announced it signed over 200 MW in 10-year AI hosting agreemen...

 sonoma-pharmaceuticals-launches-hocl-based-diaper-rash-product-in-3600-walmart-stores-and-online

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology b...

 sonoma-pharmaceuticals-q4-eps-048-beats-073-estimate-sales-375m-miss-444m-estimate

Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate o...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION